FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W145766819> ?p ?o ?g. }

• W145766819 endingPage "7" @default.
• W145766819 startingPage "714" @default.
• W145766819 abstract "To investigate the effects of β-blockers on cardiac protection and hemodynamic in patients with septic shock.A prospective randomized controlled trial was conducted. Forty-one patients with septic shock in accordance with early goal directed treatment and met the target within 6 hours, and admitted to intensive care unit (ICU) of Affiliated Huxi Hospital of Jining Medical College from January 2012 to January 2014 were enrolled. The patients were divided into treatment group (n=21) and control group (n=20) by random number table. The patients in both groups were given the standard treatment, esmolol was giving to patients in treatment group in order to control the heart rate(HR) below 100 bpm within 2 hours, and the patients in control group only received standard treatment. The changes in hemodynamic parameters [mean arterial pressure (MAP), central venous pressure (CVP), HR, cardiac index (CI), stroke volume index (SVI), systemic vascular resistance (SVRI), global end diastolic volume index (GEDVI)], biochemistry metabolic of tissue [central venous oxygen saturation (ScvO₂), lactic acid (Lac)], and cardiac markers [troponin I (cTnI)] before and 12, 24, 48, 72 hours after the treatment were recorded.(1) Before treatment, the hemodynamic parameters, tissue metabolism index and cTnI had no significant differences in both groups (all P>0.05). (2) The hemodynamic parameters after treatment in the control group showed no significant difference compared with that before treatment. HR and CI in the treatment group were gradually declined after treatment, SVRI and GEDVI were gradually increased. There were significant differences in HR, CI, SVRI, and GEDVI between treatment group and control group from 12 hours on [HR (bpm): 93 ± 4 vs. 118 ± 13, CI (L × min⁻¹ × m⁻²): 3.3 ± 0.8 vs. 4.5 ± 0.6, SVRI (kPa×s × L⁻¹ × m⁻²): 159.2 ± 27.4 vs. 130.5 ± 24.2, GEDVI (mL/m²): 668 ± 148 vs. 588 ± 103, P<0.05 or P<0.01]. MAP, CVP and SVI in the treatment group showed no significant changes. (3) Lac after treatment in both groups was decreased slowly, Lac (mmol/L) at 12 hours after treatment was significantly decreased compared with that before treatment (control group: 8.8 ± 3.2 vs. 9.8 ± 3.4, treatment group: 9.5 ± 3.1 vs. 10.5 ± 4.1, both P<0.05). The Lac of control group and treatment group were 2.5 ± 1.2 and 2.7 ± 1.1 at 72 hours after treatment, and there was no significant difference between two groups (all P>0.05). The ScvO₂was not decreased in both groups. (4) Compared with before treatment, cTnI in the control group was gradually increased, peaked at 72 hours, and that in the treatment group was gradually increased, peaked at 24 hours and then gradually declined. Compared with control group, the cTnI (μg/L) in the treatment group was decreased significantly at 24, 48, 72 hours (1.15 ± 0.57 vs. 1.74 ± 0.77, 0.93 ± 0.52 vs. 2.15 ± 1.23, 0.52 ± 0.36 vs. 2.39 ± 1.17, all P<0.01).β-blockers (esmolol) can improve cardiac function and myocardial compliance, reduce the myocardial injury in patients with sepsis shock. Although β-blockers can decrease cardiac output, it has no influence on the circulation function and tissue perfusion." @default.
• W145766819 created "2016-06-24" @default.
• W145766819 creator A5013082890 @default.
• W145766819 creator A5015041062 @default.
• W145766819 creator A5015791371 @default.
• W145766819 creator A5018938060 @default.
• W145766819 creator A5053262640 @default.
• W145766819 creator A5058479146 @default.
• W145766819 creator A5078602652 @default.
• W145766819 date "2014-10-01" @default.
• W145766819 modified "2023-10-14" @default.
• W145766819 title "[Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study]." @default.
• W145766819 doi "https://doi.org/10.3760/cma.j.issn.2095-4352.2014.10.007" @default.
• W145766819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25315942" @default.
• W145766819 hasPublicationYear "2014" @default.
• W145766819 type Work @default.
• W145766819 sameAs 145766819 @default.
• W145766819 citedByCount "9" @default.
• W145766819 countsByYear W1457668192015 @default.
• W145766819 countsByYear W1457668192016 @default.
• W145766819 countsByYear W1457668192017 @default.
• W145766819 countsByYear W1457668192018 @default.
• W145766819 countsByYear W1457668192019 @default.
• W145766819 countsByYear W1457668192021 @default.
• W145766819 countsByYear W1457668192022 @default.
• W145766819 countsByYear W1457668192023 @default.
• W145766819 crossrefType "journal-article" @default.
• W145766819 hasAuthorship W145766819A5013082890 @default.
• W145766819 hasAuthorship W145766819A5015041062 @default.
• W145766819 hasAuthorship W145766819A5015791371 @default.
• W145766819 hasAuthorship W145766819A5018938060 @default.
• W145766819 hasAuthorship W145766819A5053262640 @default.
• W145766819 hasAuthorship W145766819A5058479146 @default.
• W145766819 hasAuthorship W145766819A5078602652 @default.
• W145766819 hasConcept C126322002 @default.
• W145766819 hasConcept C139940330 @default.
• W145766819 hasConcept C164705383 @default.
• W145766819 hasConcept C178853913 @default.
• W145766819 hasConcept C2776376669 @default.
• W145766819 hasConcept C2776452961 @default.
• W145766819 hasConcept C2777628635 @default.
• W145766819 hasConcept C2777953023 @default.
• W145766819 hasConcept C2778384902 @default.
• W145766819 hasConcept C2780996683 @default.
• W145766819 hasConcept C2781300812 @default.
• W145766819 hasConcept C31861589 @default.
• W145766819 hasConcept C35207712 @default.
• W145766819 hasConcept C42219234 @default.
• W145766819 hasConcept C58245268 @default.
• W145766819 hasConcept C71924100 @default.
• W145766819 hasConcept C80461066 @default.
• W145766819 hasConcept C84393581 @default.
• W145766819 hasConceptScore W145766819C126322002 @default.
• W145766819 hasConceptScore W145766819C139940330 @default.
• W145766819 hasConceptScore W145766819C164705383 @default.
• W145766819 hasConceptScore W145766819C178853913 @default.
• W145766819 hasConceptScore W145766819C2776376669 @default.
• W145766819 hasConceptScore W145766819C2776452961 @default.
• W145766819 hasConceptScore W145766819C2777628635 @default.
• W145766819 hasConceptScore W145766819C2777953023 @default.
• W145766819 hasConceptScore W145766819C2778384902 @default.
• W145766819 hasConceptScore W145766819C2780996683 @default.
• W145766819 hasConceptScore W145766819C2781300812 @default.
• W145766819 hasConceptScore W145766819C31861589 @default.
• W145766819 hasConceptScore W145766819C35207712 @default.
• W145766819 hasConceptScore W145766819C42219234 @default.
• W145766819 hasConceptScore W145766819C58245268 @default.
• W145766819 hasConceptScore W145766819C71924100 @default.
• W145766819 hasConceptScore W145766819C80461066 @default.
• W145766819 hasConceptScore W145766819C84393581 @default.
• W145766819 hasIssue "10" @default.
• W145766819 hasLocation W1457668191 @default.
• W145766819 hasOpenAccess W145766819 @default.
• W145766819 hasPrimaryLocation W1457668191 @default.
• W145766819 hasRelatedWork W145766819 @default.
• W145766819 hasRelatedWork W2010488693 @default.
• W145766819 hasRelatedWork W2022177906 @default.
• W145766819 hasRelatedWork W2025201665 @default.
• W145766819 hasRelatedWork W2314165071 @default.
• W145766819 hasRelatedWork W2373002380 @default.
• W145766819 hasRelatedWork W2383399822 @default.
• W145766819 hasRelatedWork W2417611279 @default.
• W145766819 hasRelatedWork W3031086456 @default.
• W145766819 hasRelatedWork W3097118066 @default.
• W145766819 hasVolume "26" @default.
• W145766819 isParatext "false" @default.
• W145766819 isRetracted "false" @default.
• W145766819 magId "145766819" @default.
• W145766819 workType "article" @default.